Article
Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma
3 Sept 2020
Abstract excerpt
Neurotransmitters are reported to be involved in tumor initiation and progression. This study aimed to elucidate the prognostic value of γ-aminobutyric acid type A receptor δ subunit (GABRD) in colon adenocarcinoma (COAD) using the data from The Cancer Genome Atlas (TCGA) database. The GABRD mRNA expression levels in the COAD and normal tissues were compared using the Wilcoxon rank-sum test. The correlation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
